LC–MS/MS assay for the determination of a novel D-peptide antagonist of CXCR4 in rat plasma and its application to a preclinical pharmacokinetic study-Reference-Cited by-同舟云学术

LC–MS/MS assay for the determination of a novel D-peptide antagonist of CXCR4 in rat plasma and its application to a preclinical pharmacokinetic study

Published:2018-11 Issue: Volume:161 Page:159-167
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zhu Yinsong,Yang Shu,Wang Juan,Mao Yujia,Xu Yan,An Jing,Huang Ziwei

Funder

Tsinghua-Peking Joint Center for Life Sciences

National Institutes of Health

California Institute for Regenerative Medicine

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference19 articles.

1. Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4);Choi;J. Med. Chem.,2012

2. Emerging targets in cancer management: role of the CXCL12/CXCR4 axis;Cojoc;Onco Targets Ther.,2013

3. Small molecule inhibitors of CXCR4;Debnath;Theranostics,2013

4. Structural DNA nanotechnology for intelligent drug delivery;Chao;Small,2014

5. A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus;Kledal;Science,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Inhibition of Three Major Cytokines and Its Therapeutic Effects: A Peptide-Based Novel Therapy against Endotoxemia in Mice;Journal of Personalized Medicine;2021-05-20

2. Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors;Experimental Biology and Medicine;2020-02-04

3. Interpol review of toxicology 2016–2019;Forensic Science International: Synergy;2020